David S Tierney
CIK 1292636 · Pres and CEO · last filed 2025-12-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.82M
Companies
7
Total Filings
91
Lifetime Open-Market Net
-$2.81M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CPRX | Director | 383,314 | $31.36 | $12.02M | -$2.94M | 48 | 2025-12-30 |
| ZVRA | Director | 10,835 | $12.65 | $137.1K | $20.7K | 1 | 2023-03-13 |
| ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Director | 5,835 | $5.81 | $33.9K | $90.1K | 15 | 2022-06-30 |
| Timber Pharmaceuticals, Inc. (BPMX) Delisted | Pres and CEO | 7,500,000 | — | — | $20.2K | 3 | 2019-06-14 |
| NEXM | Director | 267,948 | $2.49 | $667.2K | $0 | 12 | 2009-10-19 |
| BIOJECT MEDICAL TECHNOLOGIES INC (BJCT) Delisted | Director | 6,000 | — | — | $0 | 6 | 2008-06-16 |
| Valera Pharmaceuticals Inc (VLRX) Delisted | President and CEO | 0 | — | — | $0 | 2 | 2007-04-18 |
Recent Filings · Page 3 of 10
91 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-12-08 | CPRX | Exer (M) | +1,334 | $0 | EDGAR |
| 2022-08-23 | CPRX | Mixed | — | -$232.6K | EDGAR |
| 2022-06-30 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Buy (P) | +2,000 | $8.8K | EDGAR |
| 2022-05-24 | CPRX | Mixed | — | $50.6K | EDGAR |
| 2022-02-16 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2021-12-30 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2021-12-06 | CPRX | Exer (M) | +1,333 | $0 | EDGAR |
| 2021-11-30 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Buy (P) | +2,000 | $15.6K | EDGAR |
| 2021-08-17 | CPRX | Mixed | — | -$147.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.